Evidence that nicotinic α7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 1112-1119

  Grottick, A J ^a   Trube, G ^a   Corrigall, W A ^a   Huwyler, J ^a   Malherbe, P ^a   Wyler, R ^a   Higgins, G A ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE FUMARATE; [4 [3 (5,6 DIHYDRO 4H[2,3']BIPYRIDINYL 3 YLIDENE)PROPENYL]PHENYL]DIMETHYLAMINE; DIHYDRO BETA ERYTHROIDINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SPIRO(1 AZABICYCLO[2.2.2]OCTANE 3,5' OXAZOLIDIN) 2' ONE; SPIRO[1 AZABICYCLO[2.2.2]OCTANE 3,2' THIAZOLIDINE] 2' ONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; HYPERACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REWARD;

ANIMALS; BRIDGED COMPOUNDS; ELECTROPHYSIOLOGY; HUMANS; LIGANDS; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; OOCYTES; PYRIDINES; PYRROLIDINES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; REWARD; SELF ADMINISTRATION; SPIRO COMPOUNDS; TRANSFECTION; XENOPUS LAEVIS;

EID: 0033847409     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
2. Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists
3. Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands
4. Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch clamp study
5. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes
6. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats
7. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats
8. Characterization of the locomotor stimulant action of nicotine in tolerant rats
9. Nicotine maintains robust self-administration in rats on a limited-access schedule
10. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area
11. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
12. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens
13. 3H]methyllycaconitine: A new radio-ligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors
14. Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics
15. 125I-α-bungarotoxin receptor subtypes
16. Methylly-caconitine: A novel nicotinic antagonist
17. Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2 and beta 4 subunits
18. Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice
19. AR-R 17779: The first high affinity, subtype-selective full agonist at the rodent α7 nicotinic acetylcholine receptor
20. 7 agonist AR-R-17779 produces cross-sensitization to the psychostimulant effects of nicotine
21. Comparison of nicotine and the alpha 7-selective agonist AR-R 17779 on nAChR α7 expressed in Xenopus oocytes
22. Neuronal nicotinic acetylcholine receptors as targets for drug discovery
23. Comparison among different approaches for sampling cerebrospinal fluid in rats
24. AR-R 17779, a selective α7 nicotinic agonist, has anxiolytic and sensory gating-enhancing properties and reduced nicotine-like side effects
25. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes
26. Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders
27. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats
28. International Union of Pharmacology XX: Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits
29. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
30. Effects of a novel cholinergic ion channel agonist SIB1765F on locomotor activity in rats
31. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviours
32. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents
33. The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes
34. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
35. Locomotor activity in rats after administration of nicotinic agonists intracerebrally
36. Pharmacological characterization of SIB-1765F: A novel cholinergic ion channel agonist
37. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: Putative role of alpha7 nicotinic receptors in the ventral tegmental area
38. Molecular cloning, functional properties and distribution of rat brain alpha 7: A nicotinic cation channel highly permeable to calcium
39. 2 subtype in the modulation of dopamine release from rat striatal synaptosomes
40. Nicotine self-administration in rats: Strain and nicotine pre-exposure effects on acquisition
41. Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats
42. A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain
43. Blockade of nicotine self-administration with nicotinic antagonists in rats
44. Megacystis, mydriasis and ion channel defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor
45. 4 subunits of neuronal nicotinic acetylcholine receptors